$0.755
+0.039 (+5.15%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DRMA Prediction & Forecast by Similar Chart Analysis
Alphio's DRMA stock price prediction model matches the current Dermata Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.91 (+3.68%). The 1-week path is $0.92 (+5.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Dermata Therapeutics Inc Stock?
Dermata Therapeutics is not a good buy right now. The current price is $0.78, and the stock has experienced a year-to-date change of -64.17%. Furthermore, the RSI is at 36.13, indicating it is nearing oversold territory but still lacks strong buying momentum. The company reported a net loss of $2.97 million in Q2 2026, which is a significant financial strain, and the cash reserves are dwindling, expected to last only until Q4 2026. The main risk is the ongoing financial losses, with a net income of -$2.97 million in Q2 2026, which raises concerns about long-term viability.
DRMA stock price ended at $0.76 on Tuesday, after rising +5.15%
Dermata Therapeutics Inc (DRMA) last closed at $0.8747, gaining +15.85%. These facts feed the 1-day and 1-week DRMA price prediction above.
Forecast Drivers
Dermata Therapeutics Inc (DRMA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches DRMA, ranked by similarity.
Seasonality analysis for DRMA
Historically the probability of a positive October return for DRMA is 0.00%. January offers the highest probability of a positive month at 29.51%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DRMA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $0.73 | $0.75 | $0.76 | -14.39% |
| Nov 2026 | $0.48 | $0.62 | $0.73 | -29.40% |
| Dec 2026 | $0.65 | $0.67 | $0.76 | -23.77% |
In 2026, Dermata Therapeutics Inc (DRMA) is projected to range from $0.48 to $0.76.
Dermata Therapeutics Inc 2026 monthly forecast
In Oct 2026, Dermata Therapeutics Inc is projected to average $0.75, with a low of $0.73 and high of $0.76.
In Nov 2026, Dermata Therapeutics Inc is projected to average $0.62, with a low of $0.48 and high of $0.73.
In Dec 2026, Dermata Therapeutics Inc is projected to average $0.67, with a low of $0.65 and high of $0.76.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.